Cancer Stem Cells in Pheochromocytoma and Paraganglioma.
adrenal
cancer stem cells
hypoxia
paraganglioma
pheochromocytoma
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2020
2020
Historique:
received:
22
11
2019
accepted:
06
02
2020
entrez:
12
3
2020
pubmed:
12
3
2020
medline:
12
3
2020
Statut:
epublish
Résumé
Pheochromocytoma (PCC) and paraganglioma (PGL) are rare neuroendocrine tumors associated with high cardiovascular morbidity and variable risk of malignancy. The current therapy of choice is surgical resection. Nevertheless, PCCs/PGLs are associated with a lifelong risk of tumor persistence or recurrence. A high rate of germline or somatic mutations in numerous genes has been found in these tumors. For some, the tumorigenic processes are initiated during embryogenesis. Such tumors carry gene mutations leading to pseudohypoxic phenotypes and show more immature characteristics than other chromaffin cell tumors; they are also often multifocal or metastatic and occur at an early age, often during childhood. Cancer stem cells (CSCs) are cells with an inherent ability of self-renewal, de-differentiation, and capacity to initiate and maintain malignant tumor growth. Targeting CSCs to inhibit cancer progression has become an attractive anti-cancer therapeutic strategy. Despite progress for this strategy for solid tumors such as neuroblastoma, brain, breast, and colon cancers, no substantial advance has been made employing similar strategies in PCCs/PGLs. In the current review, we discuss findings related to the identification of normal chromaffin stem cells and CSCs, pathways involved in regulating the development of CSCs, and the importance of the stem cell niche in development and maintenance of CSCs in PCCs/PGLs. Additionally, we examine the development and feasibility of novel CSC-targeted therapeutic strategies aimed at eradicating especially recurrent and metastatic tumors.
Identifiants
pubmed: 32158431
doi: 10.3389/fendo.2020.00079
pmc: PMC7051940
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Pagination
79Informations de copyright
Copyright © 2020 Scriba, Bornstein, Santambrogio, Mueller, Huebner, Hauer, Schedl, Wielockx, Eisenhofer, Andoniadou and Steenblock.
Références
Cell Tissue Res. 2018 May;372(2):269-275
pubmed: 29032465
Eur J Endocrinol. 2015 Jul;173(1):43-52
pubmed: 25916394
Arch Pathol Lab Med. 1985 Jul;109(7):633-5
pubmed: 3839362
Cell Mol Life Sci. 2019 Mar;76(6):1027-1039
pubmed: 30498994
Development. 2004 Nov;131(22):5599-612
pubmed: 15496445
Science. 2009 Jan 30;323(5914):630-3
pubmed: 19179530
J Anat. 1954 Oct;88(4):455-64
pubmed: 13211466
Br J Cancer. 2009 Mar 24;100(6):950-8
pubmed: 19293809
Cancers (Basel). 2011 Aug 15;3(3):3331-52
pubmed: 24212957
Cell. 2009 Oct 16;139(2):366-79
pubmed: 19837037
Elife. 2018 Jun 04;7:
pubmed: 29863471
Neuroendocrinology. 2019;109(4):287-298
pubmed: 30856620
J Cancer Res Clin Oncol. 1996;122(3):135-40
pubmed: 8601560
Cell. 1990 Feb 23;60(4):585-95
pubmed: 1689217
Cir Pediatr. 2013 Jul;26(3):112-8
pubmed: 24482902
Am J Surg Pathol. 2013 May;37(5):727-33
pubmed: 23588367
Front Mol Neurosci. 2019 Jan 25;12:6
pubmed: 30740044
Neoplasma. 2010;57(4):291-8
pubmed: 20429619
Cancer Res. 2019 Aug 15;79(16):4015-4025
pubmed: 31266772
Adv Exp Med Biol. 2013;777:3-24
pubmed: 23161072
Am J Pathol. 2007 May;170(5):1739-49
pubmed: 17456778
Hum Mol Genet. 2013 Jun 1;22(11):2169-76
pubmed: 23418310
Am J Surg Pathol. 2006 Feb;30(2):268-73
pubmed: 16434904
Science. 2017 Jul 7;357(6346):
pubmed: 28684471
Cancers (Basel). 2019 Feb 26;11(3):
pubmed: 30813557
Acta Neuropathol. 2018 May;135(5):779-798
pubmed: 29305721
Stem Cells. 2009 Oct;27(10):2602-13
pubmed: 19609938
Mol Cell. 2008 May 23;30(4):393-402
pubmed: 18498744
MAbs. 2009 Jan-Feb;1(1):41-8
pubmed: 20046573
Clin Exp Pharmacol Physiol. 2017 Feb;44(2):153-161
pubmed: 27809360
Nat Med. 2003 Sep;9(9):1158-65
pubmed: 12897778
Mod Pathol. 2003 Jun;16(6):591-7
pubmed: 12808065
Stem Cells. 2015 Jun;33(6):2037-51
pubmed: 25802118
Biochem Biophys Res Commun. 2016 Aug 19;477(2):255-9
pubmed: 27297102
Anal Cell Pathol (Amst). 2015;2015:150634
pubmed: 26258008
Annu Rev Cell Dev Biol. 2005;21:605-31
pubmed: 16212509
Kaibogaku Zasshi. 1995 Apr;70(2):130-9
pubmed: 7785412
Nat Rev Cancer. 2014 Feb;14(2):108-19
pubmed: 24442145
PLoS One. 2013 Oct 07;8(10):e76761
pubmed: 24116151
J Clin Med. 2018 Aug 27;7(9):
pubmed: 30150569
Mol Cell Endocrinol. 2017 Feb 5;441:156-163
pubmed: 27637345
Adv Pharmacol. 2013;68:285-317
pubmed: 24054150
Science. 2013 Aug 23;341(6148):860-3
pubmed: 23970693
Endocr Relat Cancer. 2010 Dec 21;18(1):97-111
pubmed: 21051559
Arch Pathol Lab Med. 1991 May;115(5):484-7
pubmed: 1673596
Elife. 2014 Sep 25;3:e03696
pubmed: 25255216
Dev Biol. 2018 Dec 1;444 Suppl 1:S25-S35
pubmed: 29454705
J Pediatr Surg. 2015 Sep;50(9):1493-501
pubmed: 25976447
FASEB J. 2019 Feb;33(2):2263-2277
pubmed: 30247985
Front Oncol. 2019 Oct 24;9:1104
pubmed: 31709180
J Clin Endocrinol Metab. 2011 Feb;96(2):375-84
pubmed: 21147885
J Clin Endocrinol Metab. 2017 Apr 1;102(4):1122-1132
pubmed: 28324046
Oncotarget. 2019 Sep 24;10(54):5645-5659
pubmed: 31608140
Front Immunol. 2018 Jan 29;9:40
pubmed: 29434587
Annu Rev Neurosci. 1993;16:129-58
pubmed: 8460888
Dev Biol. 2018 Dec 1;444 Suppl 1:S47-S59
pubmed: 29614271
Nature. 1990 Oct 25;347(6295):762-5
pubmed: 2172829
Dev Growth Differ. 2015 Feb;57(2):146-57
pubmed: 25581786
J Neurosci. 2000 Oct 1;20(19):7370-6
pubmed: 11007895
Hum Mol Genet. 2011 Oct 15;20(20):3974-85
pubmed: 21784903
J Clin Oncol. 2004 May 1;22(9):1646-54
pubmed: 15117987
Cancers (Basel). 2019 Oct 08;11(10):
pubmed: 31597347
Cancer Biol Ther. 2006 Apr;5(4):375-9
pubmed: 16575203
Cancer Cell. 2017 Feb 13;31(2):181-193
pubmed: 28162975
Am J Pathol. 1993 Jan;142(1):339-46
pubmed: 7678721
N Engl J Med. 2012 Sep 6;367(10):922-30
pubmed: 22931260
Curr Opin Genet Dev. 2017 Aug;45:10-14
pubmed: 28242477
Gynecol Endocrinol. 2018 Jan;34(1):20-24
pubmed: 28937294
Cell. 2017 Apr 6;169(2):243-257.e25
pubmed: 28388409
PLoS Genet. 2005 Jul;1(1):72-80
pubmed: 16103922
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):12997-13002
pubmed: 30514817
Dev Cell. 2009 Dec;17(6):755-73
pubmed: 20059947
Nature. 2014 Sep 25;513(7519):551-4
pubmed: 25079316
Cancer Res. 2003 May 1;63(9):2244-50
pubmed: 12727846
Lancet. 2005 Aug 20-26;366(9486):665-75
pubmed: 16112304
Cell Rep. 2017 Apr 18;19(3):471-478
pubmed: 28423311
Stem Cells Transl Med. 2012 Nov;1(11):783-91
pubmed: 23197690
Glia. 2018 Mar;66(3):465-476
pubmed: 29124786
N Engl J Med. 2009 Sep 17;361(12):1164-72
pubmed: 19726763
J Pathol. 2015 May;236(1):78-89
pubmed: 25545346
Carcinogenesis. 2013 Aug;34(8):1699-707
pubmed: 23740838
Proc Natl Acad Sci U S A. 2019 Jul 23;116(30):15068-15073
pubmed: 31285319
Int J Cancer. 2014 Nov 1;135(9):2054-64
pubmed: 24676840
Br J Cancer. 2015 Oct 20;113(8):1178-85
pubmed: 26439684
Stem Cell Investig. 2014 Apr 15;1:9
pubmed: 27358855
Cell Mol Life Sci. 2018 Jun;75(12):2177-2195
pubmed: 29541793
J Clin Endocrinol Metab. 2014 Feb;99(2):E369-73
pubmed: 24276449
Neural Dev. 2013 Jun 18;8:12
pubmed: 23777568
Cell Death Dis. 2017 Oct 5;8(10):e3072
pubmed: 28981120
Front Mol Neurosci. 2019 May 27;12:131
pubmed: 31191243